Introduction
The number of radiofrequency catheter ablation (RFA) procedures performed in the epicardial space is increasing. 1 Major acute complications (primarily pericardial bleeding) and delayed complications have been reported in 5% and 2% of cases, respectively. [2] [3] [4] To the best of our knowledge, a single case of constrictive pericarditis after multiple epicardial ablations for ventricular tachycardia has been reported. 5 We describe a late presentation of constrictive pericarditis that occurred after a single percutaneous epicardial procedure with limited ablation for inappropriate sinus tachycardia.
Case report
A 52-year-old man with asthma developed palpitations and, after extensive evaluation, was diagnosed with inappropriate sinus tachycardia. Palpitations were refractory to diltiazem and flecainide therapy, and ivabradine was unavailable. He underwent an electrophysiology study and endocardial activation mapping. RFA of the sinus node region was incomplete owing to proximity to the phrenic nerve. His symptoms became disabling and therefore, he underwent an endocardial-epicardial ablation 3 months later.
Uncomplicated percutaneous subxyphoid epicardial access was obtained with a Tuohy needle as described by Sosa et al. 6 An 8F sheath was advanced over the wire and a second long wire (Wholey) was advanced into the same sheath to implement a double wire technique. A peripheral angioplasty balloon was placed through a deflectable sheath (Agilis; St Jude Medical, Minneapolis, MN) to displace the phrenic nerve, and the RFA catheter was advanced to the right atrium (Figure 1 ). Radiofrequency energy using a Biosense-Webster Thermocool SF catheter (Diamond Bar, CA) was delivered in the endocardium. The ablation catheter and the angioplasty balloon were both removed and the ablation catheter was inserted into the epicardial space through the deflectable sheath, and 5 focal lesions were delivered in the epicardium overlying the sinus node. At the end of the procedure his heart rate decreased from 140 to 70 beats per minute. Kenalog (1 mg/kg) was injected into the pericardial space and the epicardial sheath was removed immediately after the procedure. The fluid was serous, without any evidence of bleeding, throughout the case. Twelve hours after the procedure, the patient developed pleuritic chest pain, treated with indomethacin, colchicine, and his home dose of aspirin 81 mg daily. New diffuse STsegment elevations were noted on electrocardiogram, consistent with acute pericarditis (Figure 2 ). An echocardiogram showed no effusion. His chest pain resolved in 48 hours and he was discharged 3 days after the procedure. The indomethacin and colchicine were continued for 1 month.
He was seen in follow-up at 1, 3, and 6 months and with resolution of his symptoms. No ST elevations or findings of chronic pericarditis were noted on electrocardiograms at the follow-up visits. Nine months after the epicardial ablation he returned to the clinic with dyspnea on exertion, abdominal ascites, weight gain, and lower-extremity edema requiring increasing doses of oral bumetanide. The patient was afebrile. Blood work demonstrated a normal white blood cell count, a normal thyroid-stimulating hormone level, a Westergren erythrocyte sedimentation rate of 27 mm/h (upper limit of normal is 25 mm/h), a C-reactive protein of 16 mg/L (upper limit of normal is o5 mg/L), an antinuclear antibody of 1:320 in a speckled pattern, and a negative antidouble-stranded deoxyribonucleic acid titer. An echocardiogram revealed normal biventricular function and a stress test showed a maximum workload of 6.3 metabolic equivalents and a hypotensive response to peak exercise. A cardiac magnetic resonance imaging study showed pericardial thickening with concern for constrictive pericarditis (Figure 3) . A coronary angiogram and simultaneous left and right heart catheterization demonstrated no coronary artery disease but equalization of diastolic pressures, confirming pericardial constriction ( Figure 4) . He was taken to the operating room and found to have severe global thickening of the posterior pericardium and moderate thickening of the anterior pericardium, and underwent an uncomplicated endoscopic pericardiectomy. Surgical pathology demonstrated pericardial fibrosis with focal chronic inflammation, including plasma cells ( Figure 5 ). After surgery, his symptoms improved and repeat magnetic resonance imaging demonstrated no pericardial enhancement.
Discussion
This case illustrates that constrictive pericarditis can occur as a late complication after a single percutaneous epicardial ablation procedure and should be included in the differential diagnosis of new-onset heart failure after epicardial ablation. The severity and diffuse nature of the pericardial thickening far exceeded the amount of radiofrequency energy delivered, and it is likely that the patient developed a diffuse reactive pericarditis. Given that using the angioplasty balloon to isolate the phrenic nerve involves a physical displacement of the heart, it is possible that this technique results in more diffuse pericardial inflammation in a similar way to vessel angioplasty. 7, 8 A previous occurrence of constrictive pericarditis following endocardial atrial fibrillation ablation has been reported, but the causative relationship is less evident than in procedures with direct pericardial instrumentation. 9 The contribution of the endocardial lesions to the pericarditis is uncertain. Given the absence of symptoms for 6 months, it does not appear that he had chronic clinical pericarditis. In the previously published report by Javaheri et al, 5 the development of constriction was more probable, given the repeated instrumentation of the pericardial space with 4 epicardial procedures.
Intrapericardial steroids were administered following the procedure as a prophylactic measure. D'Avila et al 10 demonstrated in a porcine model that the administration of triamcinolone prevented hemorrhagic pericarditis. The relevance of these findings to human cases requires further investigation. There are data from the cardiothoracic surgery literature that prophylactic colchicine may reduce the incidence of postpericardiotomy syndrome and therefore reduce the incidence of postoperative pericarditis. 11, 12 Prophylactic colchicine and systemic corticosteroids both reduce inflammatory markers after pulmonary vein isolation. 13, 14 However, the studies examining prophylactic colchicine did not include pericarditis as an outcome and the prophylactic steroid study had no episodes of pericarditis in either the placebo or steroid groups. 13, 14 Therefore, it is unclear at this time if there are any prophylactic pharmacologic options to reduce postablation pericarditis. Certainly, additional studies are needed.
Conclusions
To the best of our knowledge, this is the first case of pericardial constriction after a single uncomplicated percutaneous epicardial procedure with ablation limited to the right atrium. As epicardial procedures continue to evolve, it is important to recognize this rare complication. 
KEY TEACHING POINTS
Pericardial constriction should be included in the differential diagnosis of new-onset congestive heart failure after epicardial access and epicardial ablation procedures.
Pericardial constriction can occur with even small amounts of delivered radiofrequency energy and a single, uncomplicated epicardial access procedure.
Intrapericardial steroid administration may reduce the risk of pericarditis, but this finding has not been confirmed in human cases. 
